U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.

Shares of vaccine maker Moderna dropped more than 5% late Wednesday after reports that the Health and Human Services Department was re-evaluating its $590 million contract to develop a bird flu ...

HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...

American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is considering ...

The Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final days of the Biden administration to develop an mRNA vaccine for bird flu in ...

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Highly pathogenic avian influenza continues to devastate poultry flocks throughout the United States, as well as cause ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said. The review is part of a ...

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

The bird flu shot contract was awarded to Moderna in the Biden administration's final days, sending the company's stock up 13 per cent in the two days following the Jan 17 announcement ...